Haemonetics (HAE) Free Cash Flow (2009 - 2026)

Haemonetics has reported Free Cash Flow for 18 years, with the latest figure at $53.3 million in Q1 2026.

• For the quarter ending Q1 2026, Free Cash Flow fell 47.2% year-over-year to $53.3 million; the trailing twelve-month figure through Mar 2026 stood at $260.4 million (up 82.83% YoY), and the FY2026 full-year result was $260.4 million, up 82.83% from the prior year.
• Free Cash Flow for Q1 2026 stood at $53.3 million, down from $87.2 million in the prior quarter.
• The five-year high for Free Cash Flow was $106.3 million in Q3 2025, with the low at -$33.1 million in Q2 2024.
• Average Free Cash Flow over 5 years is $38.7 million, with a median of $37.6 million recorded in 2022.
• Peak annual rise in Free Cash Flow reached 526.93% in 2024, while the deepest fall reached 390.02% in 2024.
• Tracing HAE's Free Cash Flow over 5 years: stood at $47.6 million in 2022, then sank by 131.93% to -$15.2 million in 2023, then jumped by 331.92% to $35.2 million in 2024, then jumped by 147.63% to $87.2 million in 2025, then sank by 38.91% to $53.3 million in 2026.
• The last three Free Cash Flow figures came in at $53.3 million (Q1 2026), $87.2 million (Q4 2025), and $106.3 million (Q3 2025), per Business Quant data.

Peer Comparison